Key facts
- This page summarizes Arie Belldegrun's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2026, 17:04.
Arie Belldegrun - 02 Feb 2026 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)
- Reporting relationship
- Director
- Issuer ticker
- ALLO
- Reported as of
- 02 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2026, 17:04:12 UTC
- Prior SEC filing
- 27 Aug 2025
- Next SEC filing
- 24 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/Earl Douglas, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Arie Belldegrun filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 04 Feb 2026.
Change
- Previous filing in this sequence was filed on 27 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001296549
Primary reporting owner
Belldegrun Arie
- Relationship
- Director
- Address
- 210 EAST GRAND AVE, SOUTH SAN FRANCISCO
- Signature
- /s/Earl Douglas, Attorney-in-Fact
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,710,120
- Date
- 02 Feb 2026
- Ownership
- See footnote
- Footnotes
- F1
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,798,163
- Date
- 02 Feb 2026
- Ownership
- See footnote
- Footnotes
- F2
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,724,137
- Date
- 02 Feb 2026
- Ownership
- See footnote
- Footnotes
- F3
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 539,867
- Date
- 02 Feb 2026
- Ownership
- See footnote
- Footnotes
- F4
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,236,816
- Date
- 02 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALLO
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +929,913
- Change %
- Price
- $0.000000
- Shares after
- 929,913
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 929,913
- Exercise price
- $1.87
- Footnotes
- F5
ALLO
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +263,033
- Change %
- Price
- $0.000000
- Shares after
- 263,033
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 263,033
- Exercise price
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The securities are held in the name of Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary
Footnote F2
The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. There porting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Footnote F3
The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Footnote F4
The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.
Footnote F5
25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Footnote F6
Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period from February 2, 2026, subject to continued service through the vesting date.